Matches in Wikidata for { <http://www.wikidata.org/entity/Q55231464> ?p ?o ?g. }
- Q55231464 description "2018 nî lūn-bûn" @default.
- Q55231464 description "2018 թվականի մարտի 7-ին հրատարակված գիտական հոդված" @default.
- Q55231464 description "2018年の論文" @default.
- Q55231464 description "2018年学术文章" @default.
- Q55231464 description "2018年学术文章" @default.
- Q55231464 description "2018年学术文章" @default.
- Q55231464 description "2018年学术文章" @default.
- Q55231464 description "2018年学术文章" @default.
- Q55231464 description "2018年学术文章" @default.
- Q55231464 description "2018年學術文章" @default.
- Q55231464 description "2018年學術文章" @default.
- Q55231464 description "2018年學術文章" @default.
- Q55231464 description "2018年學術文章" @default.
- Q55231464 description "2018年學術文章" @default.
- Q55231464 description "2018년 논문" @default.
- Q55231464 description "article científic" @default.
- Q55231464 description "article scientific" @default.
- Q55231464 description "article scientifique" @default.
- Q55231464 description "articol științific" @default.
- Q55231464 description "articolo scientifico" @default.
- Q55231464 description "artigo científico" @default.
- Q55231464 description "artigo científico" @default.
- Q55231464 description "artigo científico" @default.
- Q55231464 description "artikel ilmiah" @default.
- Q55231464 description "artikull shkencor" @default.
- Q55231464 description "artikulong pang-agham" @default.
- Q55231464 description "artykuł naukowy" @default.
- Q55231464 description "artículo científico publicado en 2018" @default.
- Q55231464 description "artículu científicu" @default.
- Q55231464 description "bilimsel makale" @default.
- Q55231464 description "bài báo khoa học" @default.
- Q55231464 description "naučni članak" @default.
- Q55231464 description "scienca artikolo" @default.
- Q55231464 description "scientific article published on 7 March 2018" @default.
- Q55231464 description "scientific article published on 7 March 2018" @default.
- Q55231464 description "scientific article published on 7 March 2018" @default.
- Q55231464 description "teaduslik artikkel" @default.
- Q55231464 description "tieteellinen artikkeli" @default.
- Q55231464 description "tudományos cikk" @default.
- Q55231464 description "vedecký článok" @default.
- Q55231464 description "vetenskaplig artikel" @default.
- Q55231464 description "videnskabelig artikel" @default.
- Q55231464 description "vitenskapelig artikkel" @default.
- Q55231464 description "vitskapeleg artikkel" @default.
- Q55231464 description "vědecký článek" @default.
- Q55231464 description "wetenschappelijk artikel" @default.
- Q55231464 description "wissenschaftlicher Artikel" @default.
- Q55231464 description "επιστημονικό άρθρο" @default.
- Q55231464 description "мақолаи илмӣ" @default.
- Q55231464 description "наукова стаття, опублікована в березні 2018" @default.
- Q55231464 description "научна статия" @default.
- Q55231464 description "научная статья" @default.
- Q55231464 description "научни чланак" @default.
- Q55231464 description "научни чланак" @default.
- Q55231464 description "מאמר מדעי" @default.
- Q55231464 description "مقالة علمية نشرت في 7 مارس 2018" @default.
- Q55231464 description "৭ মার্চ ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q55231464 description "บทความทางวิทยาศาสตร์" @default.
- Q55231464 description "სამეცნიერო სტატია" @default.
- Q55231464 name "Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active rheumatoid arthritis: results from the phase III randomised VOLTAIRE-RA equivalence study." @default.
- Q55231464 name "Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active rheumatoid arthritis: results from the phase III randomised VOLTAIRE-RA equivalence study." @default.
- Q55231464 type Item @default.
- Q55231464 label "Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active rheumatoid arthritis: results from the phase III randomised VOLTAIRE-RA equivalence study." @default.
- Q55231464 label "Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active rheumatoid arthritis: results from the phase III randomised VOLTAIRE-RA equivalence study." @default.
- Q55231464 prefLabel "Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active rheumatoid arthritis: results from the phase III randomised VOLTAIRE-RA equivalence study." @default.
- Q55231464 prefLabel "Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active rheumatoid arthritis: results from the phase III randomised VOLTAIRE-RA equivalence study." @default.
- Q55231464 P1433 Q55231464-1596A47F-7F8D-485A-9192-026CD26F55A6 @default.
- Q55231464 P1476 Q55231464-8577C90C-3138-4329-882E-02A749138AAF @default.
- Q55231464 P2093 Q55231464-0008E88B-FAF5-4746-9A21-1655A9B3C5BD @default.
- Q55231464 P2093 Q55231464-447F79AF-383B-46C4-A47A-EB97D489CAC4 @default.
- Q55231464 P2093 Q55231464-7C8C0693-44B6-4AD2-B2F6-8E0EEF9B7CF5 @default.
- Q55231464 P2093 Q55231464-7F2DDA7A-A27E-4B26-8C06-B3B31E0C8733 @default.
- Q55231464 P2093 Q55231464-C1B1BBCB-628A-421E-8DC6-E6F55281B942 @default.
- Q55231464 P2860 Q55231464-24ED9C39-F481-469B-9353-3CBAFE942312 @default.
- Q55231464 P2860 Q55231464-746D376E-73BC-4DE4-B582-F9801DB041BA @default.
- Q55231464 P2860 Q55231464-7CC3E66C-4604-426E-987B-9E0647F36624 @default.
- Q55231464 P2860 Q55231464-C0710585-E274-4FCA-8242-94CFF0B3E943 @default.
- Q55231464 P2860 Q55231464-D3A286EF-BAD3-41A7-BBB4-E8A676EBA181 @default.
- Q55231464 P2860 Q55231464-DA8BC7BF-3E2C-4C05-BCB7-19BEE2F38FF3 @default.
- Q55231464 P304 Q55231464-67D40AFD-5836-4EA3-AE1C-ECB8CA2559EB @default.
- Q55231464 P31 Q55231464-C82AF39C-FD95-4E89-864F-5B9457FAFC6C @default.
- Q55231464 P356 Q55231464-4B22D1FB-8385-4C2F-A622-01F0A12A240D @default.
- Q55231464 P407 Q55231464-12315D16-9276-4731-916F-A86BF8151A6E @default.
- Q55231464 P433 Q55231464-79368125-E51D-4D22-BEF3-EF34BC099C5F @default.
- Q55231464 P478 Q55231464-8C9166E1-50CE-4BD6-9C63-036BE992F22F @default.
- Q55231464 P50 Q55231464-5BC44DA9-83EA-4D4D-B689-38972ADBD667 @default.
- Q55231464 P50 Q55231464-9D1C5E0E-E792-4A40-8010-D5C10AA96F97 @default.
- Q55231464 P577 Q55231464-009846FA-3F1D-42F0-9531-BB6C087305FF @default.
- Q55231464 P698 Q55231464-A99B75D6-E3D4-47E6-BAD5-62A325FCFC1C @default.
- Q55231464 P921 Q55231464-451F7A17-B9BE-486B-97E5-13AAC6FDB7B5 @default.
- Q55231464 P921 Q55231464-D4E18B8A-6B3E-45B5-AB63-D720A809645F @default.
- Q55231464 P932 Q55231464-EB58C988-74C0-4C52-B77E-9B721A4F5B0E @default.
- Q55231464 P356 ANNRHEUMDIS-2017-212245 @default.
- Q55231464 P698 29514803 @default.
- Q55231464 P1433 Q4767876 @default.
- Q55231464 P1476 "Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active rheumatoid arthritis: results from the phase III randomised VOLTAIRE-RA equivalence study." @default.
- Q55231464 P2093 "Alberto Alonso-Ruiz" @default.
- Q55231464 P2093 "Deepak Assudani" @default.
- Q55231464 P2093 "Eric C Lee" @default.
- Q55231464 P2093 "Ivo Sonderegger" @default.